Evidence map›Paper›PMID 18480237›Full record

ArticleClinical and vaccine immunology : CVI2008

Genetic and antigenic diversities of major immunoreactive proteins in globally distributed Ehrlichia canis strains.

Xiaofeng Zhang, Tian Luo, Avi Keysary, Gad Baneth, Simone Miyashiro, Carmela Strenger, Trevor Waner, Jere W McBride

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Veterinary sciences · 2024
    Review
  3. TRP36-ELISA forHeliyon · 2024
    Article
  4. Immuno- and expression analysis ofFrontiers in veterinary science · 2024
    Article
  5. Article
  6. Costa Rican Genotype ofVeterinary sciences · 2023
    Article
  7. Antibody reactive immunomes ofFrontiers in cellular and infection microbiology · 2023
    Article
  8. Article
  9. RecombinantVeterinary sciences · 2022
    Article
  10. Exposure of Domestic Cats to DistinctVeterinary sciences · 2021
    Article
  11. Effect of GP19 Peptide Hyperimmune Antiserum on Activated Macrophage duringAnimals : an open access journal from MDPI · 2021
    Article
  12. Geographic Distribution ofVeterinary sciences · 2020
    Article
  13. Article
  14. Molecular Detection and Characterization of theFrontiers in veterinary science · 2020
    Article
  15. Article
  16. Article
  17. Molecular characterization of Ehrlichia canis from naturally infected dogs from the state of Rio de Janeiro.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2019
    Article
  18. Mini-review: Strategies for Variation and Evolution of Bacterial Antigens.Computational and structural biotechnology journal · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Xiaofeng ZhangDepartment of Pathology, Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, TX 77555-0609, USA.
Tian Luo
Avi Keysary
Gad Baneth
Simone Miyashiro
Carmela Strenger
Trevor Waner
Jere W McBride
The University of Texas Medical Branch at Galveston · USIsrael Institute for Biological Research · ILBipar · FR

Funding

Protective Glycopeptide Immunodeterminants of Ehrlichia chaffeensisR01AI071145 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2006 to 2010
$1.9M
NIAID NIH HHS AI 071145-01NIAID NIH HHS R01 AI071145
6 · The paper itself

Abstract

The extent of knowledge regarding the diversity of globally distributed Ehrlichia canis strains has been limited to information gained from a few evolutionarily conserved genes. In this study, E. canis strains from the United States (strain Jake [US]), Brazil (strain São Paulo [BR]), and Israel (strain 611 [IS] and Ranana [IS-R]) were used to examine the antigenic and genetic diversities of four well-characterized major immunoreactive protein genes/proteins. gp36 and gp200 were the most divergent genes, and nucleotide substitutions in the gp36 tandem repeat region of the IS strain, but not the IS-R strain, resulted in two amino acid differences (S-->P and P-->T) in each nine-amino-acid repeat (epitope-containing region). DNA sequences of gp19 and gp140 were completely conserved in the US and BR strains, but differences were found in the Israeli strains, including two fewer tandem repeats in gp140 and a single amino acid substitution in gp19 from the IS strain. E. canis whole-cell lysates from each isolate were examined by Western immunoblotting using sera from naturally infected dogs from each country, and four major immunoreactive proteins (gp19, gp36, gp140, and gp200) were identified in each strain using protein-specific antisera. The US and BR strains exhibited highly conserved immunoreactive protein profiles, while some differences were identified in the IS strain. Sera from naturally infected Israeli dogs confirmed gene sequencing information, which demonstrated two distinct E. canis strains, defined by the gp36 gene. Conversely, gp19 was strongly reactive and present in all E. canis isolates. gp140 and gp200 were also present in all strains, although gp140 in the IS strain had two fewer tandem repeats and exhibited a smaller mass.

Indexed as

Antigenic VariationGenetic VariationAmino Acid SequenceAnimalsAntibodies, BacterialAntigens, BacterialBrazilDogsEhrlichia canisEhrlichiosisGenes, BacterialIsraelMolecular Sequence DataSequence AlignmentUnited StatesAntibodies, BacterialAntigens, Bacterial

Identifiers

PMID18480237
PMCPMC2446643
OpenAlexW2120768415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.